Arch Therapeutics completes share swap following reverse merger

Tue, 07/09/2013 - 12:29pm
Mass Device

Arch Therapeutics reports a $7.3 million financing through a share-swap related to its reverse merger with Arch Biosurgery, which marked the Arch Therapeutics’ transformation into a life sciences company.

Arch Therapeutics funding round

Cambridge, Mass.-based device company Arch Therapeutics raised $7.3 million through a stock trade in connection with its reverse merger with Arch Biosurgery.

Arch Therapeutics issued shares of its common stock in exchange for cancellation of equity or rights to acquire equity in Arch Biosurgery, according to a regulatory filing.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.